NL8401322A - Nefrotoxiciteitsinhibitoren voor aminoglycoside antibiotica. - Google Patents

Nefrotoxiciteitsinhibitoren voor aminoglycoside antibiotica. Download PDF

Info

Publication number
NL8401322A
NL8401322A NL8401322A NL8401322A NL8401322A NL 8401322 A NL8401322 A NL 8401322A NL 8401322 A NL8401322 A NL 8401322A NL 8401322 A NL8401322 A NL 8401322A NL 8401322 A NL8401322 A NL 8401322A
Authority
NL
Netherlands
Prior art keywords
acid
pharmaceutically acceptable
copolymer
aminoglycoside
acceptable salt
Prior art date
Application number
NL8401322A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8401322A publication Critical patent/NL8401322A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/29—Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyamides (AREA)
NL8401322A 1983-04-29 1984-04-25 Nefrotoxiciteitsinhibitoren voor aminoglycoside antibiotica. NL8401322A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48999983 1983-04-29
US06/489,999 US4526888A (en) 1983-04-29 1983-04-29 Nephrotoxicity inhibitors for aminoglycoside antibiotics

Publications (1)

Publication Number Publication Date
NL8401322A true NL8401322A (nl) 1984-11-16

Family

ID=23946189

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8401322A NL8401322A (nl) 1983-04-29 1984-04-25 Nefrotoxiciteitsinhibitoren voor aminoglycoside antibiotica.

Country Status (16)

Country Link
US (1) US4526888A (sv)
JP (1) JPS59206311A (sv)
AU (1) AU560158B2 (sv)
BE (1) BE899542A (sv)
CA (1) CA1227135A (sv)
CH (1) CH660457A5 (sv)
DE (1) DE3415805C2 (sv)
FR (1) FR2544986B1 (sv)
GB (1) GB2139087B (sv)
HK (1) HK74791A (sv)
IE (1) IE57409B1 (sv)
IT (1) IT1218044B (sv)
MY (1) MY100388A (sv)
NL (1) NL8401322A (sv)
SE (1) SE466288B (sv)
ZA (1) ZA843075B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH667874A5 (fr) * 1985-12-19 1988-11-15 Battelle Memorial Institute Polypeptide synthetique biodegradable et son utilisation pour la preparation de medicaments.
US5079234A (en) * 1989-03-23 1992-01-07 Bristol-Myers Squibb Co. Inhibitors of aminoglycoside nephrotoxicity
US5010092A (en) * 1989-12-22 1991-04-23 Wisconsin Alumni Research Foundation Protection against chemically-induced kidney damage by methimazole
CA2048309A1 (en) * 1990-08-28 1992-03-01 Donald N. Mcgregor Method and compositions for inhibiting aminoglycoside nephrotoxicity
US5663152A (en) * 1995-01-19 1997-09-02 Asahi Kasei Kogyo Kabushiki Kaisha Potentiators for aminoglycosides
US5876623A (en) * 1996-09-20 1999-03-02 Nalco Chemical Company Biodegradable aspartic acid polymers for preventing scale formation in boilers
US5858367A (en) * 1997-03-27 1999-01-12 Case Western Reserve University Methods for screening for antimicrobials utilizing AarC and compositions thereof
US8003595B2 (en) * 2000-03-01 2011-08-23 Cellectis Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
DE60114028T2 (de) * 2000-08-23 2006-07-13 Wockhardt Ltd. Verfahren zur herstellung von wasserfreiem azithromycin
EP1368039A4 (en) * 2001-02-20 2006-03-29 Uab Research Foundation AMINOGLYCOSIDE TREATMENT FOR LYSOSOMAL STORAGE DISEASES
US7345018B2 (en) 2002-04-25 2008-03-18 Reception Aps Method of treating side effects induced by therapeutic agents
EP1624883A4 (en) * 2003-04-09 2008-11-26 Univ Utah Res Found COMPOSITIONS AND METHODS RELATING TO THE PRODUCTION OF ERYTHROPOIETIN
US8293700B2 (en) * 2003-08-14 2012-10-23 Cellectis Anti-bacterial composition especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
FR2858772A1 (fr) * 2003-08-14 2005-02-18 Diatos Composition anti bacterienne, plus particulierement contre les bacteries gram negatif, comprenant un peptide et un agent anti-bacterien avantageusement hydrophobe

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1045109B (it) * 1969-07-03 1980-05-10 Inst Sieroterapico E Vaccino G Foli idrossi etil asparagina e metodo per la sua produzione
US3927204A (en) * 1969-07-03 1975-12-16 Sclavo Inst Sieroterapeut Use of {60 ,{62 -poly-(aspartic acid)-hydroxyalkylamides as a plasma expander
US4356166A (en) * 1978-12-08 1982-10-26 University Of Utah Time-release chemical delivery system
FR2483748A1 (fr) * 1980-06-06 1981-12-11 Corning Glass Works Procede d'hydrolyse du lactose contenu dans les lactoserums a l'aide de lactase immobilisee

Also Published As

Publication number Publication date
IE841053L (en) 1984-10-29
IT8420727A0 (it) 1984-04-27
DE3415805C2 (de) 1993-11-25
JPS59206311A (ja) 1984-11-22
DE3415805A1 (de) 1985-02-28
FR2544986B1 (fr) 1987-06-19
GB2139087A (en) 1984-11-07
AU2744284A (en) 1984-11-01
MY100388A (en) 1990-09-17
GB8410804D0 (en) 1984-06-06
CH660457A5 (de) 1987-04-30
HK74791A (en) 1991-09-27
US4526888A (en) 1985-07-02
GB2139087B (en) 1987-03-25
SE8402333D0 (sv) 1984-04-27
IT1218044B (it) 1990-03-30
SE466288B (sv) 1992-01-27
SE8402333L (sv) 1984-10-30
CA1227135A (en) 1987-09-22
JPH0553776B2 (sv) 1993-08-10
FR2544986A1 (fr) 1984-11-02
IE57409B1 (en) 1992-08-26
BE899542A (fr) 1984-10-29
AU560158B2 (en) 1987-04-02
ZA843075B (en) 1984-12-24

Similar Documents

Publication Publication Date Title
NL8401322A (nl) Nefrotoxiciteitsinhibitoren voor aminoglycoside antibiotica.
Luft et al. Experimental aminoglycoside nephrotoxicity
Yamaguchi et al. Inhibitory effects of (−)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1)
Burton et al. The role of proteinuria in the progression of chronic renal failure
Cronin et al. Natural history of aminoglycoside nephrotoxicity in the dog
Goren et al. Ifosfamide-Induced Subclinical Tubular Nephrotoxicity Despite Mesna1, 2
US6063370A (en) Macromolecular complexes for drug delivery
JP7359396B2 (ja) 細胞外ヒストンによって媒介される病理を処置及び予防するための化合物
Beauchamp et al. Attenuation of gentamicin-induced nephrotoxicity in rats by fleroxacin
Beauchamp et al. Increased nephrotoxicity of gentamicin in pyelonephritic rats
Umeki et al. Supplemental fosfomycin and/or steroids that reduce cisplatin-induced nephrotoxicity
Verpooten et al. Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients
Humbert et al. Pharmacokinetics of netilmicin in the presence of normal or impaired renal function
Hu et al. Protective effect of inhibiting necroptosis on gentamicin‐induced nephrotoxicity
Kanyok et al. Pharmacokinetics of intramuscularly administered aminosidine in healthy subjects
US20050143328A1 (en) Composition and treatment for envelope virus infections
Meyers et al. Pharmacokinetic study of netilmicin
Seale et al. Mechanisms of antibiotic-induced nephrotoxicity
Tidwell et al. Treatment of experimental Pneumocystis carinii pneumonia with analogs of pentamidine
Samaniego-Picota et al. AMINOGLYCOSIDE-INDUCEDNEPHROTOXICITY IN CYSTIC FIBROSIS: A CASE PRESENTATION AND REVIEW OF THE LITERATURE
Edelstein et al. Netilmicin therapy of serious Gram-negative bacillary infections
WO1988004925A1 (en) Protection against aminoglycoside-induced nephrotoxicity
CA2012459A1 (en) Inhibitors of aminoglycoside nephrotoxicity
Swan et al. Duration of the protective effect of polyaspartic acid on experimental gentamicin nephrotoxicity
US20120315281A1 (en) Treatment of renal injury

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable